Insights

  • Date

  • Content Type

  • Reset

Article

Redefining Statistical Significance For Rare Disease Research

15.03.23

By Christian Schneider

Biopharma Excellence recently convened three experts in the world of rare disease in a roundtable
Read More

Article

Back to the drawing board: Redefining statistical significance

28.02.23

By Christian K Schneider

A recent panel debate moderated by Christian K. Schneider, head of Biopharma Excellence, explored emerging
Read More

Article

Achieving Statistical Significance when Global Patient Populations are Limited

28.02.23

By Christian K Schneider

Highlights of a recent panel debate moderated by Christian K Schneider, head of Biopharma Excellence,
Read More

Article

The Right Materials for Success in Bioprinting

28.02.23

By Elena Meurer and Mariya Gromova

Bioprinting has enormous life-changing potential, but it is a complicated field with many regulatory hurdles.
Read More

Article

Why Regulatory Convergence is Key to Global Development of Cell and Gene Therapies

20.12.22

By Francesco Lanucara

There is growing excitement about the potential shown by cell and gene therapies, particularly in
Read More

Article

Managing the Complex Regulatory Pathways for Bioprinting Breakthroughs

20.12.22

By Elena Meurer and Mariya Gromova

Bioprinted products are already starting to demonstrate life-changing potential, but the path to commercialisation is
Read More